The Effect of Rotigotine on Memory in Idiopathic Parkinson's Disease without Cognitive Impairment

Trial Profile

The Effect of Rotigotine on Memory in Idiopathic Parkinson's Disease without Cognitive Impairment

Completed
Phase of Trial: Phase II

Latest Information Update: 17 Jun 2016

At a glance

  • Drugs Rotigotine (Primary)
  • Indications Parkinson's disease
  • Focus Adverse reactions
  • Most Recent Events

    • 13 Aug 2015 Status changed from recruiting to completed, as reported by United Kingdom Clinical Research Network record.
    • 13 Aug 2015 Accrual to date is 100% as reported by United Kingdom Clinical Research Network record.
    • 25 Jul 2015 Accrual to date is 17% as reported by United Kingdom Clinical Research Network record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top